Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN69423238Phase 3Completed
Phase 3, randomised, double-blind trial in ureterolithiasis comparing Nifedipine, Tamsulosin and Placebo (3 arms). Primary endpoints: Spontaneous passage of ureteric stones at four weeks and Incremental cost per quality-adjusted life year gained. Started Jan 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN69423238.